THE STOCKHOLM NETWORK - The leading pan-European think tank and market-oriented network
Home \ Conferences and Programmes \ Events \ IP Meetings

IP Meetings



IPRs, Foreign Direct Investment and Domestic Activities – Moving From a Zero Sum Game to a Win-Win Model
Date: 08 November 2010
Location: Ankara, Turkey
Speakers: Dr Asik Murat, Douglas Lippoldt, Prof Prabuddha Ganguli, Mehmet Gun, Derun Ulgen, Prof Serhat Unal, Dr Meir Pugatch and Helen Disney

On November 8th 2010 the Intellectual Property Academy, a joint collaboration between the Stockholm Network and MSD, hosted its inaugural meeting in Ankara, Turkey.

The meeting focused on the subject of IPRs, Foreign Direct Investment and Domestic Activities – Moving From a Zero Sum Game to a Win-Win Model?

Participants were drawn from the IP policy community and included, among others, senior government officials, academics, representatives of research centers, the legal community, and the media.

Can IPRs Be Leveraged to Generate Greater Economic Value Among OECD Countries in a Period of Economic Crisis?
Date: 08 September 2009
Location: Tel Aviv, Israel
Speakers: Doron Ben-Ami, Douglas Lippoldt, Dr Iain Gillespie, Dr Meir P. Pugatch and Helen Disney

On 8th September, the IP Academy met in Tel Aviv to discuss both: Whether IPRs can be leveraged by knowledge-based economies to promote innovation and generate greater economic value? and The essential role of intellectual assets in attracting finance, exploring different models for the life sciences sector to beat the crisis blues.

For more information on this event, please visit:
Recent IP Meeting

Evidence-Based Policy in the Field of Intellectual Property Rights
Date: 22 September 2008
Location: Paris, France
Speakers: Douglas Lippoldt, Dr Iain Gillespie, Dr Dominique Guellec, Dr Christina Sampogna, Mario Cervantes, Denis Dambois, Dr Yoav Shechter, Dr Meir Pugatch and Helen Disney

On 22nd September, the IP Academy met in Paris to discuss the following issues and topics:

MSD Israel and Stockholm Network Intellectual Property Academy - Meeting of the Tech-Transfer Group
Date: 22 January 2008
Location: Jerusalem
On 22 January 2008, the Technology-Transfer Group of the IP Academy met to deal with the issue of the exploitation of IPRs via public-private partnerships, and specifically by government-owned hospitals.

The group participated in an innovative and simulation that focused on the prioritization the key national components that are essential to tech-transfer activities in public-private partnerships.

MSD Isreal and Stockholm Network Intellectual Property Academy - Meeting of the Tech-Transfer Group
Date: 04 September 2007
Location: Tel-Aviv
Speakers: Dr Meir Pugatch, Prof. Avi Israeli, Adv. Yoel Lipschitz, Dr. Itzhak Zaidise, Mr. Jacov Mulaem, Adv. Adva Perry, Mr. Netta Cohen, Ms. Nava Swersky Sofer, Dr. Michal Roll, Mr. Pini Ben-Elazar, Dr. Sylvie Luria, Ms. Rachel Diamant, Dr. Yoav Shechter
This meeting studied the most important elements for building a successful technology-transfer model that involves collaboration between government owned hospitals and private bodies.
The Process of Intellectual Property Policy-Making
Date: 22 June 2006
Location: Jerusalem
Speakers: Prof. Michael Blakeney, Director, Queen Mary Intellectual Property Research Institute, University of London; Mr. Jon Sandelin, Senior Associate Emeritus, Stanford University Office of Technology Licensing;
This meeting studied the political process of intellectual property policy-making, and in particular, the means by which different government agencies with responsibilities in the IP field can best co-ordinate their activities.
Intellectual property policy-making in an environment with a dual structured pharmaceutical industry (innovative and generic)
Date: 16 February 2006
Location: Tel Aviv
Speakers: Prof. Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development; Mr. Barun Mitra, Founder/Director, Liberty Institute (www.libertyindia.org); Prof. Avi Israeli, Director, Ministry of Health
This meeting studied the processes of intellectual property policy-making in an environment with a dual structured pharmaceutical industry – research based and generic-based pharmaceutical companies.
The strength of intellectual property environments and foreign direct investment
Date: 28 September 2005
Location: Tel Aviv
Speakers: Mr. Douglas Lippoldt, Senior Trade Analyst, OECD Trade and Investment Directorate; Mr Jim Whelan, Business Development Manager, Irish Development Agency (IDA); Mr Jacob Harel, Senior Director, Merck Business Development Division.
The theme of the first session was the correlation between the strength of an intellectual property regime and foreign direct investment (FDI) in a given country